Back to top

Immuron Showcases Oral Antibody Platform in July 20 Investor Presentation

The latest announcement is out from Immuron ( ($IMRN) ). Immuron Limited has highlighted its expanding portfolio of orally delivered antibody-based...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

IMMURON (IMRN)